Opendata, web and dolomites

VEMoS SIGNED

Virtual eye model system for personalised refractive surgery treatment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 VEMoS project word cloud

Explore the words cloud of the VEMoS project. It provides you a very rough idea of what is the project "VEMoS" about.

skills    vissum    innovation    clinical    vemos    icpermed    global    accumulated    ophthalmic    model    educational    revolutionise    combining    social    vulnerable    58    provides    impacts    death    decision    incidence    equal    refractive    post    independent    rates    time    successful    clinics    myopia    ophthalmology    surgery    uncorrected    driving    responsible    generating    2050    39    children    ec    chuc    tomographer    profit    simulation    full    aberrometer    neural    3m    almost    front    progress    population    quantified    mature    hours    manufacturing    eye    medicine    clients    elderly    companies    satisfaction    screens    quality    simulations    2m    innovative    impairments    topographer    predicted    deficits    revolutionary    employments    ms    outcomes    economic    risk    tech    workers    28    productivity    measurable    customer    patented    revenue    network    worldwide    software    2026    treatments    2022    241bn    create    reduce    145    commercialisation    37m    virtual    cso    life    personalised    reported    50    patient    spent    auh    health    aging    vision    standardise    plan    2010    drivers    diagnostic    groups    hardware    action   

Project "VEMoS" data sheet

The following table provides information about the project.

Coordinator
VALCASADO SA 

Organization address
address: EBANISTAS 4
city: ALCORCON
postcode: 28923
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 3˙935˙335 €
 EC max contribution 2˙997˙269 € (76%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2022-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VALCASADO SA ES (ALCORCON) coordinator 1˙426˙919.00
2    COSTRUZIONI STRUMENTI OFTALMICI C.S.O. SRL IT (BADIA A SETTIMO) participant 761˙902.00
3    AARHUS UNIVERSITETSHOSPITAL DK (AARHUS) participant 406˙371.00
4    CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA E.P.E. PT (COIMBRA) participant 402˙076.00

Map

 Project objective

The incidence of myopia is predicted to rise from 28% of the global population in 2010 to almost 50% in 2050. Factors such as population aging and increase of hours spent in front of screens are driving the increase in global eye deficits. Vision impairments reduce the quality of life, affect economic and educational opportunities and increase the risk of death. This is particularly important for vulnerable groups such as elderly, children, workers and drivers. Overall, WHO reported that uncorrected vision was responsible for €241bn of productivity loss per year worldwide. Our innovative Virtual Eye Model System (VEMoS) is based on patented revolutionary ophthalmic diagnostic devices (CSO’s MS-39 tomographer/topographer and the unique open-field aberrometer), as well as on innovative simulation software developed by Vissum. Overall, our innovation provides personalised clinical-decision support based on each patient’s eye measurements and neural network simulations of post-surgery outcomes, improving surgery success and patient satisfaction rates. By combining CSO’s ophthalmic high-tech hardware design, manufacturing and commercialisation skills with Vissum’s refractive surgery and software development and independent clinical testing by CHUC and AUH, this project is expected to bring economic, social and health impacts, including progress towards achieving the EC action plan on personalised medicine “ICPerMed”. Our goal is to mature, scale-up and demonstrate the production of the VEMoS system, targeting ophthalmology clinics as clients, and with the aim to standardise refractive surgery decision making and revolutionise the refractive surgery field with personalised treatments. A successful VEMoS project will allow us to create measurable impacts on our companies, quantified as accumulated revenue of €145.3m in five years (2022-2026), equal to accumulated operating profit of €58.2m, creating 60 full time employments, and generating €37m in reduced customer costs.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VEMOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VEMOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

Bio-LP-1 (2020)

A novel rapid environmental test for the human pathogen Legionella

Read More  

PATH-TOX (2018)

Artificial Intelligence to transform Drug and Chemical safety testing

Read More  

SAMBAfun (2018)

System for AcceleroMeter-Based Assessment of cardiac FUNction

Read More